Cancer Grand Challenges
Overview
Cancer Grand Challenges is a global funding initiative, co-founded by Cancer Research UK and the US National Cancer Institute, that provides large-scale grants to multidisciplinary research teams tackling the toughest challenges in cancer.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Boundless Bio | Jun 2022 | Grant | Co-investor |
| Yemaachi Biotechnology | Mar 2024 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cancer Grand Challenges based?
Cancer Grand Challenges is headquartered in London, United Kingdom.
When was Cancer Grand Challenges founded?
Cancer Grand Challenges was founded in 2020.
How many portfolio companies does Cancer Grand Challenges have?
Cancer Grand Challenges has 2 portfolio companies in Caplight's dataset.
What are some companies in Cancer Grand Challenges's portfolio?
Portfolio companies visible on Caplight include Boundless Bio, Yemaachi Biotechnology.
What was Cancer Grand Challenges's most recent investment shown here?
Cancer Grand Challenges's most recent investment in this portfolio sample was in Yemaachi Biotechnology in 2024.
What sectors does Cancer Grand Challenges focus on?
Cancer Grand Challenges focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Cancer Grand Challenges focus on?
Stage focus information for Cancer Grand Challenges is not publicly available.